Adicet Bio's Series A Round

Adicet Bio raised a round of funding on January 27, 2016.

Adicet Bio is a privately held, pre-clinical stage biotechnology company engaged in the design and development of immunotherapies for cancer and other disease indications, with a focus on universal im…

Articles about Adicet Bio's Series A Round: